Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2019 | 12-2018 | 06-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,454 | 3,520 | 5,284 | 4,056 | 4,845 |
| Marketable Securities | N/A | N/A | 50 | 1,250 | 2,000 |
| Inventories | 41 | 42 | 56 | 56 | 56 |
| Other current assets | 1,004 | 1,374 | 1,011 | 599 | 704 |
| TOTAL | $3,499 | $4,936 | $6,401 | $5,961 | $7,605 |
| Non-Current Assets | |||||
| PPE Net | 556 | 333 | 374 | 15 | 12 |
| Intangibles | 16 | 22 | 29 | 37 | 45 |
| TOTAL | $572 | $355 | $403 | $52 | $57 |
| Total Assets | $4,071 | $5,291 | $6,804 | $6,013 | $7,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 161 | 988 | 305 | 926 | 282 |
| TOTAL | $1,691 | $988 | $777 | $926 | $1,103 |
| Non-Current Liabilities | |||||
| TOTAL | $127 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,818 | $988 | $777 | $926 | $1,103 |
| Shareholders' Equity | |||||
| Common Shares | 1,094 | 1,094 | 1,094 | 914 | 914 |
| Retained earnings | -27,586 | -25,536 | -23,812 | -22,081 | -20,609 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $2,253 | $4,303 | $6,027 | $5,087 | $6,559 |
| Total Liabilities And Equity | $4,071 | $5,291 | $6,804 | $6,013 | $7,662 |